Met Life Investment Management, LLC Immunovant, Inc. Transaction History

Met Life Investment Management, LLC

  • $16.6 Billion
  • Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Immunovant, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 33,608 shares of IMVT stock, worth $924,556. This represents 0.01% of its overall portfolio holdings.

Number of Shares
33,608
Previous 28,477 18.02%
Holding current value
$924,556
Previous $920,000 3.59%
% of portfolio
0.01%
Previous 0.01%

Shares

40 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
BUY
$25.1 - $31.61 $128,788 - $162,190
5,131 Added 18.02%
33,608 $887,000
Q1 2024

May 14, 2024
BUY
$30.27 - $43.79 $861,998 - $1.25 Million
28,477 New
28,477 $920,000
Q3 2023

May 09, 2024
BUY
$18.55 - $39.96 $112,913 - $243,236
6,087 Added 27.19%
28,477 $1.09 Million
Q2 2023

Apr 29, 2024
BUY
$14.2 - $23.75 $404,373 - $676,328
28,477 New
28,477 $540,000
Q2 2023

Aug 10, 2023
BUY
$14.2 - $23.75 $86,435 - $144,566
6,087 Added 27.19%
28,477 $540,000
Q1 2023

May 09, 2024
BUY
$15.27 - $19.72 $341,895 - $441,530
22,390 New
22,390 $347 Million
Q1 2023

May 15, 2023
BUY
$15.27 - $19.72 $11,345 - $14,651
743 Added 3.43%
22,390 $347,000
Q4 2022

Jun 14, 2023
SELL
$6.59 - $17.75 $4,896 - $13,188
-743 Reduced 3.32%
21,647 $384,000
Q3 2022

May 10, 2024
SELL
$3.93 - $6.37 $13,900 - $22,530
-3,537 Reduced 14.04%
21,647 $120,000
Q3 2022

Jun 14, 2023
SELL
$3.93 - $6.37 $2,919 - $4,732
-743 Reduced 3.32%
21,647 $120,000
Q3 2022

Mar 22, 2023
SELL
$3.93 - $6.37 $13,900 - $22,530
-3,537 Reduced 14.04%
21,647 $120,000
Q3 2022

Nov 14, 2022
BUY
$3.93 - $6.37 $85,072 - $137,891
21,647 New
21,647 $121,000
Q2 2022

Aug 11, 2022
SELL
$3.38 - $5.65 $85,121 - $142,289
-25,184 Closed
0 $0
Q1 2022

May 10, 2024
BUY
$5.06 - $8.77 $127,431 - $220,863
25,184 New
25,184 $138,000
Q1 2022

Jun 20, 2023
BUY
$5.06 - $8.77 $14,137 - $24,503
2,794 Added 12.48%
25,184 $138,000
Q1 2022

Mar 22, 2023
BUY
$5.06 - $8.77 $103,107 - $178,706
20,377 Added 423.9%
25,184 $138,000
Q1 2022

May 12, 2022
BUY
$5.06 - $8.77 $103,107 - $178,706
20,377 Added 423.9%
25,184 $139,000
Q4 2021

May 17, 2024
SELL
$7.33 - $9.32 $74,780 - $95,082
-10,202 Reduced 67.97%
4,807 $40,000
Q4 2021

Jun 21, 2023
SELL
$7.33 - $9.32 $128,883 - $163,873
-17,583 Reduced 78.53%
4,807 $40,000
Q4 2021

Mar 22, 2023
SELL
$7.33 - $9.32 $74,780 - $95,082
-10,202 Reduced 67.97%
4,807 $40,000
Q4 2021

Feb 15, 2022
SELL
$7.33 - $9.32 $74,780 - $95,082
-10,202 Reduced 67.97%
4,807 $41,000
Q3 2021

May 17, 2024
BUY
$7.01 - $11.37 $75,708 - $122,795
10,800 Added 256.59%
15,009 $130,000
Q3 2021

Jun 21, 2023
SELL
$7.01 - $11.37 $51,740 - $83,921
-7,381 Reduced 32.97%
15,009 $130,000
Q3 2021

Mar 22, 2023
BUY
$7.01 - $11.37 $75,708 - $122,795
10,800 Added 256.59%
15,009 $130,000
Q3 2021

Nov 15, 2021
BUY
$7.01 - $11.37 $75,708 - $122,795
10,800 Added 256.59%
15,009 $130,000
Q2 2021

May 17, 2024
SELL
$9.4 - $16.85 $101,501 - $181,946
-10,798 Reduced 71.95%
4,209 $44,000
Q2 2021

Jun 21, 2023
SELL
$9.4 - $16.85 $170,901 - $306,349
-18,181 Reduced 81.2%
4,209 $44,000
Q2 2021

Mar 22, 2023
SELL
$9.4 - $16.85 $101,501 - $181,946
-10,798 Reduced 71.95%
4,209 $44,000
Q2 2021

Aug 16, 2021
SELL
$9.4 - $16.85 $101,501 - $181,946
-10,798 Reduced 71.95%
4,209 $44,000
Q1 2021

May 17, 2024
SELL
$13.08 - $49.6 $176,187 - $668,112
-13,470 Reduced 47.3%
15,007 $240,000
Q1 2021

Jun 26, 2023
SELL
$13.08 - $49.6 $96,569 - $366,196
-7,383 Reduced 32.97%
15,007 $241 Million
Q4 2020

Jun 22, 2023
SELL
$36.36 - $52.71 $268,445 - $389,157
-7,383 Reduced 32.97%
15,007 $693,000
Q3 2020

May 24, 2024
BUY
$22.61 - $38.9 $125,711 - $216,284
5,560 Added 58.85%
15,007 $528 Million
Q3 2020

Jun 26, 2023
SELL
$22.61 - $38.9 $166,929 - $287,198
-7,383 Reduced 32.97%
15,007 $528,000
Q3 2020

Mar 22, 2023
BUY
$22.61 - $38.9 $125,711 - $216,284
5,560 Added 58.85%
15,007 $528,000
Q3 2020

Nov 13, 2020
BUY
$22.61 - $38.9 $125,711 - $216,284
5,560 Added 58.85%
15,007 $528,000
Q2 2020

May 24, 2024
SELL
$13.87 - $28.44 $263,946 - $541,213
-19,030 Reduced 66.83%
9,447 $230 Million
Q2 2020

Jun 26, 2023
SELL
$13.87 - $28.44 $179,519 - $368,098
-12,943 Reduced 57.81%
9,447 $230,000
Q2 2020

Mar 22, 2023
SELL
$13.87 - $28.44 $169,214 - $346,968
-12,200 Reduced 56.36%
9,447 $230,000
Q2 2020

Aug 14, 2020
BUY
$13.87 - $28.44 $131,029 - $268,672
9,447 New
9,447 $230,000

Others Institutions Holding IMVT

# of Institutions
220
Shares Held
65.1M
Call Options Held
697K
Put Options Held
629K
View Full List

About Immunovant, Inc.

IMVT Quotes by TradingView
  • Ticker IMVT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,077,000
  • Market Cap $3.55B
  • Description
  • Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of mya...
More about IMVT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email